Mar 11, 2025

USA - English Share this article Share toX Next-Gen Therapies and Data-Driven Innovation Take Center Stage as Industry Leaders Explore AI-Led Patient-Centric Strategies to Revolutionize Drug Commercialization BERKELEY HEIGHTS, N.J., March 11, 2025 /PRNewswire/ --  Axtria Inc.,  an AI-first data analytics company for the life sciences industry, is set to disrupt the status quo with "Axtria Ignite 2025" – the must-attend conference for senior industry leaders. Taking place on June 4-5 in Princeton, N.J., this annual event will dive deep into "Leadership in an Agentic Era," while probing the groundbreaking innovations transforming data insights that empower faster, smarter decision-making. Get ready to accelerate your strategy and redefine what's possible in life sciences. "Axtria Ignite 2025 is set to be our most impactful event yet, sparking bold conversations and unparalleled networking for life sciences leaders eager to stay ahead of the curve in the rapidly evolving worlds of AI, GenAI, and Agentic technology," said Jaswinder "Jassi" Chadha, President and CEO of Axtria. "We're excited to lead the charge into the future with Axtria Ignite 2025, reinforcing our commitment to revolutionizing the life sciences industry through innovation, collaboration, and relentless forward-thinking." Three focus areas that will help attendees embrace change, seize bold opportunities, and gain valuable insights include: Next-Gen Therapies. From breakthrough technologies and evolving regulations to shifting customer demands, attendees will learn new ways to commercialize rare, orphan, cell, and gene therapies and use the power of data and technology to deliver unparalleled value to patients. Patients at the Heart of Operations. In a world overflowing with opportunities, attendees will explore how to navigate them strategically, ensuring the patient always comes first while identifying high-impact business opportunities. AI, GenAI, and the move to Agentic AI. Attendees will dive into the revolutionary potential of AI, GenAI, and cutting-edge Agentic AI. They will learn real-world success stories – and failures – that will inspire them to lead the charge as a change agent. Ignite your passion, knowledge, and growth at Axtria Ignite 2025. Interested? Click here to learn more and request your registration. About Axtria's Products and Solutions Axtria is proud to work with 16 of the top 20 life sciences companies, globally. From our roots as a trusted consultant to our status as one of the world's leading providers of cloud-based pharmaceutical management software , Axtria powers digital transformations in life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria InsightsMAx™ helps everyone from the C-suite to junior associates uncover trends to make better decisions. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration. About Axtria Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We're proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit  www.axtria.com . SOURCE Axtria, Inc.